None listed
Conditions
Interventions
None listed
Sponsors
Hanyang University Seoul Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Inclusion criteria 1) patients who were prescribed oral antiviral agents for a treatment of CHB during the study period 2) CHB patients with episode of liver decompensation defined as the occurence of complications such as refractory ascites, variceal bleeding, encephalopathy, or hepatorenal syndrome. 3) patients of any age of either sex
Exclusion criteria
Exclusion criteria: 2. Exclusion criteria 1) patients who were diagnosted with all cancer before a treatment of CHB
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival analysis according to the medication compliance of antiviral agents | — |
Secondary
| Measure | Time frame |
|---|---|
| reccurence rate analysis of decompensated liver cirrhosis complication according to the medication compliance of antiviral agents | — |
Countries
Korea, Republic of
Contacts
Public ContactDae Jun
Hanyang University
Outcome results
None listed